Clinical Trials · NCT06324461
GLP-1 Receptor Agonist for Reduction of Myocardial Injury After Non-cardiac Surgery
- Phase
- Phase 4
- Recruitment status
- Recruiting
- Sponsor
- The University of Hong Kong
- Enrollment
- 372
- Start date
- Mar 2024
- Locations
- 3 sites, China
- Primary endpoint
- Proportion of patients with MINS